
Janux Therapeutics (JANX) Earnings Dates & Reports
Janux Therapeutics (JANX) Most Recent Earnings
Report DateMay 8, 2025
Period EndingQ1 2025
Est. EPS-$0.39
Actual EPS-$0.38
EarningsBeat
Janux Therapeutics (JANX) Earnings
View the latest Janux Therapeutics (JANX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Janux Therapeutics (JANX)
Order type
Buy in
Order amount
Est. shares
0 shares
Janux Therapeutics (JANX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Janux Therapeutics (JANX) Latest Earnings
The value each JANX share was expected to gain vs. the value each share gained.
Janux Therapeutics (JANX) reported its most recent earnings on May 8, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.38. This exceeded analysts' expectations of -$0.39 by 2.56%, marking a Beat.
For comparison, Janux Therapeutics reported EPS of -$0.30 in the same quarter last year.
The company is expected to announce its next earnings report on 08/06/2025, with analysts projecting an EPS of $0.
Janux Therapeutics (JANX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 6, 2025 | – | Next earnings call Aug. 6, 2025 | ||
Q1 2025May 8, 2025 | -$0.39 | -$0.38 | -2.56% | |
Q4 2024Feb 27, 2025 | -$0.45 | -$0.36 | -20.00% | |
Q3 2024Nov 5, 2024 | -$0.33 | -$0.51 | +54.55% | |
Q2 2024Aug 7, 2024 | -$0.31 | -$0.11 | -64.52% | |
Janux Therapeutics (JANX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Janux Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 8, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 6, 2024 | — | — | — |
Aug 7, 2024 | — | — | — |
Janux Therapeutics (JANX) Earnings FAQs
Janux Therapeutics (JANX) last reported earnings on May 8, 2025 for Q1 2025, posting an EPS of -$0.38, which Beat the estimate of -$0.39 by 2.56%.
For Q1 2025, Janux Therapeutics (JANX) reported an EPS of -$0.38, exceeding analysts' estimate of -$0.39 by 2.56%.
For Q1 2025, Janux Therapeutics (JANX) Beat expectations with an actual EPS of -$0.38 vs. an estimated EPS of -$0.39.
Following the last earnings report on May 8, 2025, Janux Therapeutics (JANX)'s stock price moved — from — to —.
The next Janux Therapeutics (JANX) earnings call is scheduled for Aug. 6, 2025, where executives will discuss financial results and outlook.